← Research library

A comparison of the anxiolytic effect and tolerability of Selank and phenazepam in anxiety disorders

Comparison in people · 2014

What was studied
60 adults in an open study. Random assignment was reported: 30 Selank and 30 phenazepam.
Main finding
At day 14 the anxiety subscore fell 26.3% with Selank vs 55% with phenazepam. A week after stopping therapy, the paper reported 17 vs 9 responders (p=0.037).

Reported findings and study design

Open randomized comparison of 30 Selank and 30 phenazepam recipients. Response was defined as at least a 50% reduction in total HDRS score.

Population or model 60 adults in an open study. Random assignment was reported: 30 Selank and 30 phenazepam.

Dose, route and schedule

Selank 2.7 mg/day or phenazepam 2 mg/day for 14 days. Assessments at baseline and days 7, 14 and 21. The checked paper does not specify routes in the regimen paragraph.

Protocol source ↗ · Publisher full text, including arm allocation, response criteria and adverse-event table.

Results · Publisher full text, including arm allocation, response criteria and adverse-event table.
MeasureResultComparison, timing and statistics
Anxiety-subscore reduction26.3% vs 55%Selank vs phenazepam · Day 14
Responders at end of treatment5/30 vs 7/30Day 14
Responders after stopping treatment17/30 vs 9/30Day 21 · p=0.037
Reported sleepiness or sedation0% vs 87%Day 7

Phenazepam had larger symptom-score reductions during treatment. The later response comparison favored Selank after one week off medication. The short open trial had no placebo arm.

Source for these results ↗ · Reviewed 2026-11-14

Study limitations and source details

Study limitations

  • Open active-comparator design with no placebo. Details of the randomization and allocation procedures are sparse.
  • One week of post-treatment observation provides limited evidence about durability, withdrawal and long-term safety. Possible overlap with the later phenazepam study remains unresolved.

Source details

Journal publication

Publisher full text, including arm allocation, response criteria and adverse-event table.

Sources checked

Citation

Human comparative studyFull text available

V E Medvedev, O N Tereshchenko, A Iu Israelian, I K Chobanu, N V Kost, O Iu Sokolov, N F Miasoedov. A comparison of the anxiolytic effect and tolerability of Selank and phenazepam in anxiety disorders Zh Nevrol Psikhiatr Im S S Korsakova. 114(7):17–22

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards